WHO ICTRP trial
An observational study of children immunised in infancy against hepatitis B…
EUCTR2008-004785-98-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-004785-98-GB |
|---|---|
| Public title | An observational study of children immunised in infancy against hepatitis B virus, evaluating the persistence of immunity and the immune response to a scheduled booster dose of hepatitis B vaccine - Hepatitis B childhood booster study |
| Scientific title | An observational study of children immunised in infancy against hepatitis B virus, evaluating the persistence of immunity and the immune response to a scheduled booster dose of hepatitis B vaccine - Hepatitis B childhood booster study |
| Primary sponsor | University of Oxford |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | United Kingdom |
| Conditions | The intended application of Engerix B is active immunisation against Hepatitis B virus infection caused by all known subtypes in non immune subjects. MedDRA version: 9.1 Level: LLT Classification code 10052552 Term: Hepatitis B virus |
| Interventions | Trade Name: Engerix B Pharmaceutical Form: Suspension for injection INN or Proposed INN: HEPATITIS B SURFACE ANTIGEN ADSORBED Other descriptive name: HEPATITIS B SURFACE ANTIGEN ADSORBED Concentration unit: µg/ml microgram(s)/millilitre… |
| Registration date | Jan 20, 2009 |
| Target size | 55 |
| Secondary IDs | OVG2008/5 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: